Assessment and management of newly diagnosed classical Hodgkin lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance

被引：1

作者：

Cochrane, Tara ^{[1
,2
]}

Campbell, Belinda A. ^{[3
,4
,5
]}

Gangatharan, Shane A. ^{[6
,7
]}

Latimer, Maya ^{[8
]}

Khor, Richard ^{[9
]}

Christie, David R. H. ^{[10
,11
]}

Gilbertson, Michael ^{[12
,13
,14
]}

Ratnasingam, Sumita ^{[15
]}

Palfreyman, Emma ^{[16
]}

Lee, Hui-Peng ^{[17
]}

Trotman, Judith ^{[18
,19
]}

Hertzberg, Mark ^{[20
,21
]}

Dickinson, Michael ^{[5
,22
,23
]}

机构：

[1] Gold Coast Univ Hosp, Dept Haematol, Gold Coast, Qld, Australia

[2] Griffiths Univ, Sch Med, Gold Coast, Qld, Australia

[3] Peter MacCallum Canc Ctr, Dept Radiat Oncol, Melbourne, Vic, Australia

[4] Univ Melbourne, Dept Clin Pathol, Parkville, Vic, Australia

[5] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia

[6] Fiona Stanley Hosp, Perth, WA, Australia

[7] Univ Western Australia, Perth, WA, Australia

[8] ACT Pathol & Canberra Hosp, Canberra, ACT, Australia

[9] Austin Hosp, Melbourne, Vic, Australia

[10] Genesiscare, Gold Coast, Qld, Australia

[11] Bond Univ, Gold Coast, Qld, Australia

[12] Monash Hlth, Melbourne, Vic, Australia

[13] Monash Univ, Sch Clin Sci, Melbourne, Vic, Australia

[14] Western Hlth, Dept Haematol & Oncol, Melbourne, Vic, Australia

[15] Univ Hosp Geelong, Andrew Love Canc Ctr, Geelong, Vic, Australia

[16] Royal Darwin Hosp, Darwin, NT, Australia

[17] Flinders Med Ctr, Adelaide, SA, Australia

[18] Concord Repatriat Gen Hosp, Sydney, NSW, Australia

[19] Univ Sydney, Sydney, NSW, Australia

[20] Prince Wales Hosp, Dept Haematol, Sydney, NSW, Australia

[21] Univ NSW, Sydney, NSW, Australia

[22] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[23] Royal Melbourne Hosp, Melbourne, Vic, Australia

来源：

INTERNAL MEDICINE JOURNAL | 2021年 / 51卷 / 12期

关键词：

Hodgkin lymphoma; PET adapted; chemotherapy; HL; radiotherapy; BREAST-CANCER RISK; POSITRON-EMISSION-TOMOGRAPHY; ACUTE MYELOID-LEUKEMIA; PRIMARY THYROID-CANCER; RADIATION-THERAPY; CHILDHOOD-CANCER; OPEN-LABEL; BRENTUXIMAB VEDOTIN; ADAPTED TREATMENT; PROGNOSTIC SCORE;

D O I：

10.1111/imj.15503

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The management of Hodgkin lymphoma (HL) has undergone significant changes in recent years. Due to the predilection of HL to affect younger patients, balancing cure and treatment-related morbidity is a constant source of concern for physicians and patients alike. Positron emission tomography adapted therapy has been developed for both early and advanced stage HL to try and improve the outcome of treatment, while minimising toxicities. The aim of this review is to digest the plethora of studies recently conducted and provide some clear, evidence-based practice statements to simplify the management of HL.

引用

页码：2119 / 2128

页数：10

共 50 条

[41] Comparative effectiveness of treatments for newly diagnosed follicular non-Hodgkin lymphoma
Messori, Andrea
Fadda, Valeria
Maratea, Dario
Trippoli, Sabrina
LEUKEMIA & LYMPHOMA, 2015, 56 (09) : 2728 - 2730
[42] CNS involvement in children with newly diagnosed non-Hodgkin's lymphoma
Sandlund, JT
Murphy, SB
Santana, VM
Behm, F
Jones, D
Berard, CW
Furman, WL
Ribeiro, R
Crist, WM
Greenwald, C
Chen, G
Walter, A
Pui, CH
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) : 3018 - 3024
[43] A systematic review of therapeutic regimens for older patients with newly diagnosed Hodgkin lymphoma
Allen, Pamela B.
Ayers, Amy
Behera, Madhusmita
Evens, Andrew M.
Flowers, Christopher
LEUKEMIA & LYMPHOMA, 2020, 61 (07) : 1555 - 1564
[44] Active Surveillance for Newly Diagnosed Nodular Lymphocyte-Predominant Hodgkin Lymphoma
Borchmann, Sven
Joffe, Erel
Moskowitz, Craig H.
Zelenetz, Andrew D.
Noy, Ariela
Portlock, Carol S.
Gerecitano, John F.
Batlevi, Connie
Caron, Philip
Drullinsky, Pamela
Hamilton, Audrey
Hamlin, Paul A., Jr.
Horwitz, Steven M.
Kumar, Anita
Matasar, Matthew J.
Moskowitz, Alison J.
Owens, Colette N.
Palomba, Lia
Younes, Anas
Straus, David J.
BLOOD, 2017, 130
[45] Hemophagocytic Lymphohistiocytosis and Hodgkin Lymphoma in a Newly Diagnosed HIV Patient: A Diagnostic Dilemma
Okobi, Tobechukwu J.
Cautha, Sandhya
Bhatt, Tanushree
Atogwe, Irhoboudu Dickson
Schmidt, Patrik
Patel, Dhruv
Khaja, Misbahuddin
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (06)
[46] Guideline on the management of primary resistant and relapsed classical Hodgkin lymphoma
Collins, Graham P.
Parker, Anne N.
Pocock, Christopher
Kayani, Irfan
Sureda, Anna
Illidge, Tim
Ardeshna, Kirit
Linch, David C.
Peggs, Karl S.
BRITISH JOURNAL OF HAEMATOLOGY, 2014, 164 (01) : 39 - 52
[47] Doxorubicin, Etoposide, Vinblastine and Dacarbazine (AEVD) for Newly Diagnosed Classic Hodgkin Lymphoma
de Lacerda, Marcelo Pitombeira
de Oliveira, Julio Cesar
Jungles, Sergio, Jr.
Macedo, Gabriela Sirydakis
Tomazelli, Ana Paula
Baptista, Joao Pedro Ribeiro
Dall'Oglio, Ana Claudia
Gastal, Gabriela Roncone
Boettcher, Ivan Schneider
Tavares, Fabiana Sanchez
Dobner, Soraya
BLOOD, 2021, 138
[48] Novel targeted immunotherapy in newly diagnosed adolescent and young adults with Hodgkin lymphoma
Hochberg, Jessica
BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 : 14 - 14
[49] Cell-Free DNA for the Management of Classical Hodgkin Lymphoma
Camus, Vincent
Jardin, Fabrice
PHARMACEUTICALS, 2021, 14 (03)
[50] Management of relapsed and refractory classical Hodgkin lymphoma in children and adolescents
Daw, Stephen
Wynn, Rob
Wallace, Hamish
BRITISH JOURNAL OF HAEMATOLOGY, 2011, 152 (03) : 249 - 260

← 1 2 3 4 5 →